nitrofurantoin has been researched along with aspirin in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (41.94) | 18.7374 |
| 1990's | 3 (9.68) | 18.2507 |
| 2000's | 7 (22.58) | 29.6817 |
| 2010's | 8 (25.81) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duffy, EM; Jorgensen, WL | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Balko, KM; Colby, DA; Mo, H | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bender, A; Czobor, P; Jelinek, B; Málnási-Csizmadia, A; Peragovics, Á; Simon, Z; Tombor, L; Végner, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Jick, H; Porter, J | 1 |
| de Gaetano, G; Donati, MB; Garattini, S | 1 |
| Chan, TK; Todd, D; Tso, SC | 1 |
| Ben-Meir, S; Herman, J | 1 |
| Bryant, DH | 1 |
| Cooper, JA; Matthay, RA | 1 |
| Rosenow, EC | 1 |
| Levin, NW; Rossi, EC | 1 |
| De Szöcs, J; Grant, DJ | 1 |
| Cameron, D; Necheles, TF; Steinberg, MH | 1 |
| Kolts, BE; Langfitt, M | 1 |
| Foster, MG; Wright, LA | 1 |
| Gerhardsson de Verdier, M; Steineck, G; Wiholm, BE | 1 |
| Carrión Valero, F; Marín Pardo, J | 1 |
| LOCKEY, SD | 1 |
5 review(s) available for nitrofurantoin and aspirin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug-induced pulmonary disease.
Topics: Adrenergic beta-Antagonists; Adverse Drug Reaction Reporting Systems; Aerosols; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Agents; Aspirin; Bronchial Spasm; Contrast Media; Cough; Drug-Related Side Effects and Adverse Reactions; Humans; Lung Diseases; Nitrofurantoin | 1992 |
Drug-induced pulmonary disease.
Topics: Anti-Arrhythmia Agents; Anticonvulsants; Antineoplastic Agents; Aspirin; Gold; Humans; Hydrochlorothiazide; Narcotics; Nitrofurantoin; Penicillamine; Pulmonary Edema; Pulmonary Fibrosis; Respiratory Hypersensitivity; Ritodrine; Sulfasalazine; Terbutaline | 1987 |
The spectrum of drug-induced pulmonary disease.
Topics: Adrenal Cortex Hormones; Aerosols; Analgesics; Aspirin; Autonomic Agents; Bleomycin; Busulfan; Contraceptives, Oral; Cyclophosphamide; Dextropropoxyphene; Drug Hypersensitivity; Heroin; Humans; Lung Diseases; Lupus Erythematosus, Systemic; Methadone; Methotrexate; Mineral Oil; Nitrofurantoin; Oxygen Inhalation Therapy; Paraquat; Pituitary Gland, Posterior; Pleural Effusion; Sulfonamides; Tissue Extracts | 1972 |
[Pulmonary toxicity caused by drugs].
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Anti-Infective Agents, Urinary; Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antineoplastic; Antineoplastic Agents; Aspirin; Bleomycin; Drug-Related Side Effects and Adverse Reactions; Humans; Lung; Lung Diseases; Nitrofurantoin; Oxygen Inhalation Therapy; Platelet Aggregation Inhibitors; Pulmonary Fibrosis; Radiography, Thoracic; Respiratory Insufficiency; Vasodilator Agents | 1999 |
26 other study(ies) available for nitrofurantoin and aspirin
| Article | Year |
|---|---|
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A practical deuterium-free NMR method for the rapid determination of 1-octanol/water partition coefficients of pharmaceutical agents.
Topics: 1-Octanol; Magnetic Resonance Spectroscopy; Pharmaceutical Preparations; Water | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Experimental confirmation of new drug-target interactions predicted by Drug Profile Matching.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Animals; CHO Cells; Cricetulus; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Molecular Conformation; Molecular Targeted Therapy; Peptidyl-Dipeptidase A; Receptors, Dopamine D1; Receptors, Dopamine D2; Structure-Activity Relationship; Substrate Specificity | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Drug-induced gastrointestinal bleeding. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center.
Topics: Anticoagulants; Aspirin; Chlordiazepoxide; Drug Therapy, Combination; Ethacrynic Acid; Gastrointestinal Hemorrhage; Glucocorticoids; Heparin; Humans; Nitrofurantoin; Warfarin | 1978 |
Clinical importance of side-effects of drugs inhibiting platelet function.
Topics: Aspirin; Carbenicillin; Female; Hemorrhage; Humans; Nitrofurantoin; Penicillin G; Platelet Aggregation; Pregnancy; Salicylates | 1977 |
Drug-induced haemolysis in glucose-6-phosphate dehydrogenase deficiency.
Topics: Aspirin; Cell Survival; China; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Male; Nitrofurantoin; Primaquine; Stimulation, Chemical; Sulfamethoxazole; Time Factors | 1976 |
Overt hemolysis in patients with glucose-6-phosphate dehydrogenase deficiency: a survey in general practice.
Topics: Adolescent; Adult; Aminopyrine; Anemia, Hemolytic; Aspirin; Child, Preschool; Chloramphenicol; Dipyrone; Ethnicity; Favism; Female; Glucosephosphate Dehydrogenase; Humans; Infant; Infant, Newborn; Israel; Male; Middle Aged; Nitrofurantoin; Streptomycin; Sulfadiazine | 1975 |
Lung disease caused by drugs.
Topics: Aspirin; Asthma; Contraceptives, Oral; Drug-Related Side Effects and Adverse Reactions; Eosinophilia; Female; Humans; Lung Diseases; Lupus Erythematosus, Systemic; Nitrofurantoin; Polyarteritis Nodosa; Propranolol; Pulmonary Edema; Pulmonary Embolism | 1969 |
Inhibition of primary ADP-induced platelet aggregation in normal subjects after administration of nitrofurantoin (furadantin).
Topics: Adenosine Diphosphate; Administration, Oral; Aspirin; Blood Platelets; Buffers; Collagen; Depression, Chemical; Female; Humans; Kinetics; Nitrofurantoin; Prostaglandins; Theophylline; Time Factors | 1973 |
Inhibitory effects of some anti-inflammatory and other analgesics and nitrofurans on the induction of -galactosidase synthesis in Klebsiella aerogenes.
Topics: Acetaminophen; Analgesics; Anti-Inflammatory Agents; Aspirin; Enzyme Induction; Furazolidone; Galactosidases; Klebsiella; Morphine; Nalorphine; Niridazole; Nitrofurans; Nitrofurantoin; Nitrofurazone; Phenacetin; Salicylamides; Salicylates | 1971 |
Erythrocyte glutathione-peroxidase deficiency.
Topics: Adolescent; Adult; Anemia, Hemolytic, Congenital; Aspirin; Child; Child, Preschool; Erythrocytes; Glutathione; Hemolysis; Humans; Infant; Infant, Newborn; Jaundice, Neonatal; Metabolism, Inborn Errors; Middle Aged; Nitrofurantoin; Pedigree; Peroxidases; Sulfisoxazole | 1970 |
Drugs and the liver.
Topics: Acetaminophen; Adult; Aspirin; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Cholestasis; Cimetidine; Fatty Liver; Female; Hepatic Artery; Hepatic Veins; Humans; Ketoconazole; Liver; Liver Diseases; Liver Neoplasms; Methyldopa; Necrosis; Nitrofurantoin; Peliosis Hepatis; Portal Vein; Valproic Acid; Verapamil | 1984 |
Effect of some commonly prescribed drugs on certain chemistry tests.
Topics: Acetaminophen; Ascorbic Acid; Aspartate Aminotransferases; Aspirin; Bilirubin; Blood Chemical Analysis; Blood Glucose; Calcium; Carbon Dioxide; Cholesterol; Humans; Methyldopa; Nitrofurantoin; Pharmacology; Tetracycline; Uric Acid | 1980 |
Acetaminophen, some other drugs, some diseases and the risk of transitional cell carcinoma. A population-based case-control study.
Topics: Acetaminophen; Age Factors; Analgesics; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Aspirin; Asthma; Carcinoma, Transitional Cell; Case-Control Studies; Confidence Intervals; Disease; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Nitrofurantoin; Population Surveillance; Reproducibility of Results; Rheumatic Diseases; Risk Factors; Sex Factors; Smoking; Sweden; Tetracyclines; Urinary Tract Infections; Urologic Neoplasms | 1995 |
ADVERSE REACTIONS TO DRUGS.
Topics: Anaphylaxis; Anti-Bacterial Agents; Aspirin; Chemical and Drug Induced Liver Injury; Chloramphenicol; Colistin; Drug Eruptions; Drug Hypersensitivity; Hepatitis; Nitrofurantoin; Novobiocin; Penicillins; Polymyxins; Protein Synthesis Inhibitors; Serum Sickness; Streptomycin; Tetracycline; Toxicology | 1964 |